FI921641A - Förfarande för framställning av terapeutiskt användbara 1-(pyrido/3,4-b/-1,4-oxazin-4-yl)-1H-indoler - Google Patents

Förfarande för framställning av terapeutiskt användbara 1-(pyrido/3,4-b/-1,4-oxazin-4-yl)-1H-indoler Download PDF

Info

Publication number
FI921641A
FI921641A FI921641A FI921641A FI921641A FI 921641 A FI921641 A FI 921641A FI 921641 A FI921641 A FI 921641A FI 921641 A FI921641 A FI 921641A FI 921641 A FI921641 A FI 921641A
Authority
FI
Finland
Prior art keywords
loweralkyl
hydrogen
chem
oxazin
indoles
Prior art date
Application number
FI921641A
Other languages
English (en)
Finnish (fi)
Other versions
FI97544C (sv
FI97544B (sv
FI921641A0 (sv
Inventor
Richard Charles Effland
Larry Davis
Gordon Edward Olsen
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI921641A0 publication Critical patent/FI921641A0/sv
Publication of FI921641A publication Critical patent/FI921641A/sv
Application granted granted Critical
Publication of FI97544B publication Critical patent/FI97544B/sv
Publication of FI97544C publication Critical patent/FI97544C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI921641A 1991-04-15 1992-04-13 Förfarande för framställning av terapeutiskt användbara 1-(pyrido/3,4-b/-1,4-oxazin-4-yl)-1H-indoler FI97544C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/684,758 US5214038A (en) 1991-04-15 1991-04-15 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US68475891 1991-04-15

Publications (4)

Publication Number Publication Date
FI921641A0 FI921641A0 (sv) 1992-04-13
FI921641A true FI921641A (sv) 1992-10-16
FI97544B FI97544B (sv) 1996-09-30
FI97544C FI97544C (sv) 1997-01-10

Family

ID=24749434

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921641A FI97544C (sv) 1991-04-15 1992-04-13 Förfarande för framställning av terapeutiskt användbara 1-(pyrido/3,4-b/-1,4-oxazin-4-yl)-1H-indoler

Country Status (22)

Country Link
US (3) US5214038A (sv)
EP (1) EP0509400B1 (sv)
JP (1) JP2608359B2 (sv)
KR (1) KR100201509B1 (sv)
AT (1) ATE140006T1 (sv)
AU (1) AU643135B2 (sv)
CA (1) CA2065986C (sv)
CZ (1) CZ282054B6 (sv)
DE (1) DE69211892T2 (sv)
DK (1) DK0509400T3 (sv)
ES (1) ES2094840T3 (sv)
FI (1) FI97544C (sv)
GR (1) GR3020612T3 (sv)
HU (1) HUT62588A (sv)
IE (1) IE74907B1 (sv)
IL (1) IL101589A (sv)
NO (1) NO301765B1 (sv)
NZ (2) NZ248131A (sv)
PL (1) PL168671B1 (sv)
RU (1) RU2042680C1 (sv)
TW (1) TW211016B (sv)
ZA (1) ZA922721B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
WO2003022813A1 (fr) * 2001-09-07 2003-03-20 Ono Pharmaceutical Co., Ltd. Derives indole, methode de fabrication et medicaments renfermant lesdits derives en tant que principe actif
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
MX2011007864A (es) 2009-01-28 2011-09-30 Karus Therapeutics Ltd Isosteros para realzar la transcripcion y su uso en terapia.
JP6329958B2 (ja) * 2012-11-07 2018-05-23 カルス セラピューティクス リミテッド 新規ヒストンデアセチラーゼインヒビターおよび治療におけるその使用
KR20160007577A (ko) 2013-05-10 2016-01-20 카루스 떼라퓨틱스 리미티드 신규한 히스톤 디아세틸라제 억제제들
GB201419264D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
GB201419228D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
RU2769507C1 (ru) 2018-08-13 2022-04-01 Ф. Хоффманн-Ля Рош Аг Новые гетероциклические соединения как ингибиторы моноацилглицеринлипазы
KR20220062515A (ko) 2019-09-12 2022-05-17 에프. 호프만-라 로슈 아게 Magl 억제제로서 4,4a,5,7,8,8a-헥사피리도[4,3-b][1,4]옥사진-3-온 화합물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029657A (en) * 1976-06-14 1977-06-14 The Dow Chemical Company 6,7-Dichloro-3,4-dihydro-2H-pyrazino(2,3-B)(1,4)oxazines
DE2726437A1 (de) * 1977-06-11 1978-12-21 Bayer Ag Hydrazonfarbstoffe
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
US5039811A (en) * 1987-04-24 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-(pyridinyl)-1H-indol-1-amines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
ES2068294T3 (es) * 1989-08-02 1995-04-16 Hoechst Roussel Pharma 2,3-dihidro-1-(piridinilamino)-indoles, un procedimiento para su preparacion y su uso como medicamentos.
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines

Also Published As

Publication number Publication date
ES2094840T3 (es) 1997-02-01
IE74907B1 (en) 1997-08-13
EP0509400A1 (en) 1992-10-21
HUT62588A (en) 1993-05-28
KR100201509B1 (ko) 1999-06-15
FI97544C (sv) 1997-01-10
NO301765B1 (no) 1997-12-08
PL168671B1 (pl) 1996-03-29
DE69211892T2 (de) 1996-12-19
DK0509400T3 (da) 1996-10-28
CA2065986C (en) 2006-02-21
CS113592A3 (en) 1992-11-18
NO921490L (no) 1992-10-16
US5276156A (en) 1994-01-04
CZ282054B6 (cs) 1997-05-14
CA2065986A1 (en) 1992-10-16
AU643135B2 (en) 1993-11-04
US5519131A (en) 1996-05-21
IE921190A1 (en) 1992-10-21
NZ242309A (en) 1995-07-26
US5214038A (en) 1993-05-25
DE69211892D1 (de) 1996-08-08
RU2042680C1 (ru) 1995-08-27
ATE140006T1 (de) 1996-07-15
NO921490D0 (no) 1992-04-14
FI97544B (sv) 1996-09-30
EP0509400B1 (en) 1996-07-03
KR920019796A (ko) 1992-11-20
ZA922721B (en) 1992-11-25
TW211016B (sv) 1993-08-11
IL101589A0 (en) 1992-12-30
AU1485292A (en) 1992-10-22
NZ248131A (en) 1995-07-26
HU9201290D0 (en) 1992-07-28
JPH05112572A (ja) 1993-05-07
FI921641A0 (sv) 1992-04-13
JP2608359B2 (ja) 1997-05-07
PL294221A1 (en) 1993-08-09
GR3020612T3 (en) 1996-10-31
IL101589A (en) 1996-10-31

Similar Documents

Publication Publication Date Title
NZ221543A (en) 4-aminoquinoline derivatives and pharmaceutical compositions containing such
NZ235460A (en) Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl-carbamate derivatives and pharmaceutical compositions
FI921641A (sv) Förfarande för framställning av terapeutiskt användbara 1-(pyrido/3,4-b/-1,4-oxazin-4-yl)-1H-indoler
EP0468401A3 (en) 1-(substituted pyridinylamino)-1h-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments
NZ215439A (en) Benzo(c) 1,5 naphthyridines and pharmaceutical compositions
NO911998D0 (no) Pyrido(3,4-b)(pyrrolo(1,2-e)(1,4,5)oksadiazepin og beslektede analoger og fremgangsmaate for fremstilling derav.
NO178372C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive karbamoyl-1-(pyrindinylalkyl)-1H-indoler

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL, INC.

PC Transfer of assignment of patent

Owner name: AVENTIS PHARMACEUTICALS INC.